A detailed history of Geode Capital Management, LLC transactions in Passage Bio, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 431,110 shares of PASG stock, worth $301,777. This represents 0.0% of its overall portfolio holdings.

Number of Shares
431,110
Previous 384,278 12.19%
Holding current value
$301,777
Previous $518,000 34.36%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$0.79 - $1.58 $36,997 - $73,994
46,832 Added 12.19%
431,110 $340,000
Q1 2024

May 13, 2024

BUY
$0.86 - $1.73 $44,784 - $90,089
52,075 Added 15.68%
384,278 $518,000
Q3 2023

Nov 13, 2023

BUY
$0.66 - $1.01 $190 - $291
289 Added 0.09%
332,203 $219,000
Q4 2022

Feb 13, 2023

SELL
$1.06 - $1.48 $21,860 - $30,522
-20,623 Reduced 5.85%
331,914 $458,000
Q3 2022

Nov 14, 2022

BUY
$1.22 - $2.48 $988 - $2,008
810 Added 0.23%
352,537 $440,000
Q2 2022

Aug 12, 2022

SELL
$1.63 - $3.46 $478,541 - $1.02 Million
-293,584 Reduced 45.49%
351,727 $830,000
Q1 2022

May 13, 2022

SELL
$2.66 - $6.49 $71,857 - $175,320
-27,014 Reduced 4.02%
645,311 $2 Million
Q4 2021

Feb 11, 2022

BUY
$6.24 - $10.2 $1.24 Million - $2.03 Million
198,997 Added 42.04%
672,325 $4.27 Million
Q3 2021

Nov 12, 2021

SELL
$9.73 - $15.52 $542,612 - $865,503
-55,767 Reduced 10.54%
473,328 $4.71 Million
Q2 2021

Aug 13, 2021

BUY
$12.44 - $19.45 $1.05 Million - $1.65 Million
84,605 Added 19.03%
529,095 $7.01 Million
Q1 2021

May 12, 2021

BUY
$16.24 - $29.83 $2 Million - $3.68 Million
123,371 Added 38.42%
444,490 $7.77 Million
Q4 2020

Feb 12, 2021

BUY
$14.28 - $29.73 $1.53 Million - $3.19 Million
107,372 Added 50.23%
321,119 $8.21 Million
Q3 2020

Nov 13, 2020

BUY
$12.39 - $26.15 $28,323 - $59,778
2,286 Added 1.08%
213,747 $2.8 Million
Q2 2020

Aug 13, 2020

BUY
$14.59 - $36.07 $3.09 Million - $7.63 Million
211,461 New
211,461 $5.78 Million

Others Institutions Holding PASG

About Passage BIO, Inc.


  • Ticker PASG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,463,200
  • Market Cap $38.1M
  • Description
  • Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...
More about PASG
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.